Article
KRAS Inhibitors Are Potential Prophylaxis for Colorectal Cancer Metachronous Metastasis
2024-03-21
Abstract excerpt
Colorectal cancer (CRC) with KRAS mutation is prone to develop metachronous metastasis. However, effective measures for prediction and prevention of such clinical issue are currently unavailable. In this study, we confirmed that KRAS mutation is a risk factor for CRC metachronous metastasis through meta-analysis and public database analysis. Based on the ICGC-AGRO database, we have constructed a risk scoring model...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8354efa6-096f-5753-a03a-1c0b95c97c4a
- DOI
- 10.20944/preprints202403.1095.v1
